Serum levels of interleukin 15 in patients with rheumatic diseases

Journal of Rheumatology

Volumn 28, Issue 11, 2001, Pages 2389-2391

  Suzuki, J ^a   Morimoto, S ^a   Amano, H ^a   Tokano, Y ^a   Takasaki, Y ^a   Hashimoto, H ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dermatomyositis polymyositis; Hemophagocytic syndrome; Interleukin 15; Interstitial pneumonitis; Polyarteritis nodosa; Systemic sclerosis

Indexed keywords

INTERLEUKIN 15;

ADOLESCENT; ADULT; AGED; ARTICLE; CORRELATION FUNCTION; CYTOKINE RELEASE; DERMATOMYOSITIS; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOPHAGOCYTIC SYNDROME; HUMAN; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POLYARTERITIS NODOSA; POLYMYOSITIS; PRIORITY JOURNAL; PROGNOSIS; RHEUMATIC DISEASE; SURVIVAL; SYSTEMIC SCLEROSIS; VASCULITIS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; DERMATOMYOSITIS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTIOCYTOSIS, NON-LANGERHANS-CELL; HUMANS; INTERLEUKIN-15; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; POLYARTERITIS NODOSA; SCLERODERMA, SYSTEMIC; VASCULITIS;

EID: 0034766276     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor
2. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor
3. IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation
4. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
5. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression
6. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis
7. Preliminary criteria for the classification of systemic sclerosis (scleroderma)
8. The 1982 revised criteria for the classification of systemic lupus erythematosus
9. The American College of Rheumatology 1990 criteria for the classification of vasculitis
10. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus
11. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis
12. Interleukin-15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and the SCID mouse-human rheumatoid arthritis model in vivo
13. Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndrome
14. Differences of biodistribution, pharmacokinetics, and tumor targeting between interleukin 2 and 15